Given reports of tumor-reactive CD8+ T-cell populations in patients with multiple myeloma (51), the proximity of CD8+ T cells to tumor cells may represent increased immune activity in multiple myeloma, and the “homing” of CD8+ T cells to tumor sites. The gene discussed is CD8A; the disease is AL amyloidosis.